Identification of semaphorin E as a non-MDR drug resistance gene of human cancers

T Yamada, R Endo, M Gotoh… - Proceedings of the …, 1997 - National Acad Sciences
T Yamada, R Endo, M Gotoh, S Hirohashi
Proceedings of the National Academy of Sciences, 1997National Acad Sciences
To improve cancer chemotherapy, a better understanding of the molecular mechanisms of
drug resistance is essential. To identify the molecules responsible for drug resistance that is
unrelated to MDR1 or MRP gene products, a eukaryotic expression cDNA library of cis-
diamminedichloroplatinum (II)(CDDP)-resistant ovarian cancer TYKnuR cells was
introduced into Cos-7 cells. After repeated CDDP selection, cDNA homologous to murine
semaphorin E was isolated from surviving cells. Human semaphorin E (H-sema E) was …
To improve cancer chemotherapy, a better understanding of the molecular mechanisms of drug resistance is essential. To identify the molecules responsible for drug resistance that is unrelated to MDR1 or MRP gene products, a eukaryotic expression cDNA library of cis-diamminedichloroplatinum(II) (CDDP)-resistant ovarian cancer TYKnuR cells was introduced into Cos-7 cells. After repeated CDDP selection, cDNA homologous to murine semaphorin E was isolated from surviving cells. Human semaphorin E (H-sema E) was overexpressed in CDDP-resistant cell lines and was readily induced not only by diverse chemotherapeutic drugs but also by x-ray and UV irradiation. Transfection of H-sema E conferred a drug-resistant phenotype to CDDP-sensitive cells. In addition, the aberrant expression of H-sema E protein was detected immunohistochemically in 14 of 42 (33.3%) recurrent squamous cell carcinomas removed at autopsy after extensive radiochemotherapy. Recently, another member of the semaphorin family, CD100, was shown to significantly improve the viability of B lymphocytes. These results suggest the involvement of semaphorins in diverse cell survival mechanisms.
National Acad Sciences